X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA STRIDES SHASUN LTD PLETHICO PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x -1.1 15.2 - View Chart
P/BV x 0.0 1.8 0.9% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 PLETHICO PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
STRIDES SHASUN LTD
Mar-17
PLETHICO PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3951,275 31.0%   
Low Rs31918 3.4%   
Sales per share (Unadj.) Rs604.4389.6 155.2%  
Earnings per share (Unadj.) Rs32.528.0 116.1%  
Cash flow per share (Unadj.) Rs51.348.9 105.0%  
Dividends per share (Unadj.) Rs04.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs473.6303.1 156.2%  
Shares outstanding (eoy) m34.0889.42 38.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.42.8 12.5%   
Avg P/E ratio x6.639.2 16.7%  
P/CF ratio (eoy) x4.222.4 18.5%  
Price / Book Value ratio x0.53.6 12.4%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m7,26298,036 7.4%   
No. of employees `000NA5.8 0.0%   
Total wages/salary Rs m1,5965,881 27.1%   
Avg. sales/employee Rs ThNM6,005.9-  
Avg. wages/employee Rs ThNM1,014.0-  
Avg. net profit/employee Rs ThNM431.2-  
INCOME DATA
Net Sales Rs m20,59834,834 59.1%  
Other income Rs m3861,686 22.9%   
Total revenues Rs m20,98436,520 57.5%   
Gross profit Rs m2,8186,428 43.8%  
Depreciation Rs m6421,872 34.3%   
Interest Rs m1,5932,269 70.2%   
Profit before tax Rs m9693,973 24.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m04 0.0%   
Extraordinary Inc (Exp) Rs m0-1,006 0.0%   
Tax Rs m-138470 -29.4%   
Profit after tax Rs m1,1072,501 44.3%  
Gross profit margin %13.718.5 74.1%  
Effective tax rate %-14.311.8 -120.8%   
Net profit margin %5.47.2 74.8%  
BALANCE SHEET DATA
Current assets Rs m18,87738,165 49.5%   
Current liabilities Rs m11,89630,402 39.1%   
Net working cap to sales %33.922.3 152.1%  
Current ratio x1.61.3 126.4%  
Inventory Days Days3677 46.5%  
Debtors Days Days198104 189.4%  
Net fixed assets Rs m9,86137,639 26.2%   
Share capital Rs m341894 38.1%   
"Free" reserves Rs m12,33126,210 47.0%   
Net worth Rs m16,13927,105 59.5%   
Long term debt Rs m4,70616,377 28.7%   
Total assets Rs m33,14681,168 40.8%  
Interest coverage x1.62.8 58.5%   
Debt to equity ratio x0.30.6 48.3%  
Sales to assets ratio x0.60.4 144.8%   
Return on assets %8.15.9 138.6%  
Return on equity %6.99.2 74.3%  
Return on capital %12.312.1 102.0%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,40213,465 32.7%   
Fx outflow Rs m3,1844,076 78.1%   
Net fx Rs m1,2199,389 13.0%   
CASH FLOW
From Operations Rs m2,4372,881 84.6%  
From Investments Rs m-6,265-7,051 88.8%  
From Financial Activity Rs m2,4903,382 73.6%  
Net Cashflow Rs m-1,337-788 169.8%  

Share Holding

Indian Promoters % 82.7 27.7 298.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 37.8 11.4%  
FIIs % 5.5 8.6 64.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 25.9 29.0%  
Shareholders   10,665 56,241 19.0%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   PIRAMAL ENTERPRISES  GSK PHARMA  DR. DATSONS LABS  DR. REDDYS LAB  NOVARTIS  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - LUPIN LTD COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS